Overview Bioequivalence of the Tablet and Liquid-Filled Capsule Forms of MK0974 (0974-042) Status: Completed Trial end date: 2008-05-01 Target enrollment: Participant gender: Summary This study will demonstrate the definitive bioequivalence of a solid dose formulation of MK0974 to the liquid filled capsule formulation of MK0974. Phase: Phase 1 Details Lead Sponsor: Merck Sharp & Dohme Corp.